# Non-Invasive Screening for Fetal Aneuploidy

> **NCT02317965** · — · UNKNOWN · sponsor: **Progenity, Inc.** · enrollment: 340 (estimated)

## Conditions studied

- Down Syndrome
- Edwards Syndrome

## Interventions

- **OTHER:** Maternal Blood Draw

## Key facts

- **NCT ID:** NCT02317965
- **Lead sponsor:** Progenity, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2018-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02317965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02317965, "Non-Invasive Screening for Fetal Aneuploidy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02317965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*